Cancer Res Treat > v.55(4)

31 results

1063 Barriers in Oligometastasis Care in Korea: Radiation Oncologists’ Perspectives
Eui Kyu Chie, Chai Hong Rim, Won Kyung Cho, Yong Chan Ahn
KMSID: 1516084190   Cancer Res Treat. 2023;55(4):1063-1064.   Published online 2023 June 27    DOI: http://dx.doi.org/10.4143/crt.2023.780
      
1065 Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor–Positive Breast Cancer
Eunice Yoojin Lee, Dae-Won Lee, Kyung-Hun Lee, Seock-Ah Im
KMSID: 1516084194   Cancer Res Treat. 2023;55(4):1065-1076.   Published online 2023 October 5    DOI: http://dx.doi.org/10.4143/crt.2023.846
      
1077 Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients
Wonyoung Choi, Yun-Hee Kim, Sang Myung Woo, Yebeen Yu, Mi Rim Lee, Woo Jin Lee, Jung Won Chun, Sung Hoon Sim, Heejung Chae, Hyoeun Shim, Keun Seok Lee, Sun-Young Kong
KMSID: 1516084173   Cancer Res Treat. 2023;55(4):1077-1086.   Published online 2023 June 12    DOI: http://dx.doi.org/10.4143/crt.2022.1630
      
1087 Clinicopathological Characteristics of NRG1 Fusion–Positive Solid Tumors in Korean Patients
Yoon Jin Cha, Chung Lee, Bio Joo, Kyung A Kim, Choong-kun Lee, Hyo Sup Shim
KMSID: 1516084192   Cancer Res Treat. 2023;55(4):1087-1095.   Published online 2023 June 15    DOI: http://dx.doi.org/10.4143/crt.2023.682
      
1096 A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy
Young-Woong Won, Jin-Hyoung Kang, Jung Hye Kwon, Dong-Hoe Koo, Jung Hun Kang, Chi Hoon Maeng, Hee Kyung Ahn, Sung Yong Oh, Dae-Won Lee, Joohyuk Sohn, So Yeon Oh, Kyung Hee Lee, Su-Jin Koh, Keun Seok Lee, Chan-Kyu Kim, Ji-Yeon Kim, Jun Ho Ji, Sung-Bae Kim, Joo Young Ha, Ho Young Kim
KMSID: 1516084176   Cancer Res Treat. 2023;55(4):1096-1103.   Published online 2023 April 7    DOI: http://dx.doi.org/10.4143/crt.2022.1565
      
1104 Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Hana Kim, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Keunchil Park, Yong Chan Ahn, Dongryul Oh, Myung-Ju Ahn
KMSID: 1516084189   Cancer Res Treat. 2023;55(4):1104-1112.   Published online 2023 May 17    DOI: http://dx.doi.org/10.4143/crt.2023.502
      
1113 Individualized Concurrent Chemotherapy for Patients with Stage III–IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy
Pengjie Ji, Qiongjiao Lu, Xiaoqiang Chen, Yuebing Chen, Xiane Peng, Zhiwei Chen, Cheng Lin, Shaojun Lin, Jingfeng Zong
KMSID: 1516084177   Cancer Res Treat. 2023;55(4):1113-1122.   Published online 2023 May 11    DOI: http://dx.doi.org/10.4143/crt.2022.1651
      
1123 Outcomes of Salvage Therapy for Oropharyngeal Cancer Recurrence Following Upfront Radiation Therapy and Prognostic Factors
Nayeon Choi, Hack Jung Kim, Heejun Yi, Heejung Kim, Tae Hwan Kim, Han-Sin Jeong, Young-Ik Son, Chung-Hwan Baek, Dongryul Oh, Yong Chan Ahn, Man Ki Chung
KMSID: 1516084165   Cancer Res Treat. 2023;55(4):1123-1133.   Published online 2023 May 8    DOI: http://dx.doi.org/10.4143/crt.2022.1046
      
1134 Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer
Miso Kim, Soyeon Kim, Jeemin Yim, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Dae Seog Heo
KMSID: 1516084181   Cancer Res Treat. 2023;55(4):1134-1143.   Published online 2023 May 23    DOI: http://dx.doi.org/10.4143/crt.2023.311
      
1144 Expanded Access Program Pralsetinib in Advanced Non–Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement
Youngkyung Jeon, Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Se-Hoon Lee
KMSID: 1516084184   Cancer Res Treat. 2023;55(4):1144-1151.   Published online 2023 May 22    DOI: http://dx.doi.org/10.4143/crt.2023.403
      
1152 Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non–Small Cell Lung Cancer: Updated Analysis of the RESET Study
Taeyun Kim, Tae Won Jang, Chang Min Choi, Mi-Hyun Kim, Sung Yong Lee, Yoon Soo Chang, Kye Young Lee, Seung Joon Kim, Sei Hoon Yang, Jeong Seon Ryu, Jeong Eun Lee, Shin Yup Lee, Chan Kwon Park, Sang Hoon Lee, Seung Hun Jang, Seong Hoon Yoon, Hyung-Joo Oh
KMSID: 1516084193   Cancer Res Treat. 2023;55(4):1152-1170.   Published online 2023 May 19    DOI: http://dx.doi.org/10.4143/crt.2023.493
      
1171 Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non–Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry
Jeonghee Yun, Jong Ho Cho, Tae Hee Hong, Kyungmi Yang, Yong Chan Ahn, Hong Kwan Kim
KMSID: 1516084174   Cancer Res Treat. 2023;55(4):1171-1180.   Published online 2023 April 17    DOI: http://dx.doi.org/10.4143/crt.2022.1581
      
1181 Clinical Outcome of Stereotactic Body Radiotherapy in Patients with Early-Stage Lung Cancer with Ground-Glass Opacity Predominant Lesions: A Single Institution Experience
Jeong Yun Jang, Su Ssan Kim, Si Yeol Song, Young Seob Shin, Sei Won Lee, Wonjun Ji, Chang-Min Choi, Eun Kyung Choi
KMSID: 1516084179   Cancer Res Treat. 2023;55(4):1181-1189.   Published online 2023 March 21    DOI: http://dx.doi.org/10.4143/crt.2022.1656
      
1190 Should We Perform Repeated Re-biopsy for the Detection of T790M Mutation?
Saerom Kim, Soo Han Kim, Jinmi Kim, Mi-Hyun Kim, Min Ki Lee, Jung Seop Eom
KMSID: 1516084180   Cancer Res Treat. 2023;55(4):1190-1197.   Published online 2023 April 17    DOI: http://dx.doi.org/10.4143/crt.2023.320
      
1198 Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor–Positive Metastatic Breast Cancer
Seul-Gi Kim, Min Hwan Kim, Sejung Park, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Byeong Woo Park, Seung Il Kim, Jung Hwan Ji, Joon Jeong, Kabsoo Shin, Jieun Lee, Hyung-Don Kim, Kyung Hae Jung, Joohyuk Sohn
KMSID: 1516084172   Cancer Res Treat. 2023;55(4):1198-1209.   Published online 2023 April 11    DOI: http://dx.doi.org/10.4143/crt.2022.1543
      
1210 Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy
Youzhao Ma, Mingda Zhu, Jingyang Zhang, Minhao Lv, Xiuchun Chen, Zhenzhen Liu
KMSID: 1516084175   Cancer Res Treat. 2023;55(4):1210-1221.   Published online 2023 April 4    DOI: http://dx.doi.org/10.4143/crt.2022.1633
      
1222 Health-Seeking Behavior Returning to Normalcy Overcoming COVID-19 Threat in Breast Cancer
Eun-Gyeong Lee, Yireh Han, Dong-Eun Lee, Hyeong-Gon Moon, Hyoung Won Koh, Eun-Kyu Kim, So-Youn Jung
KMSID: 1516084183   Cancer Res Treat. 2023;55(4):1222-1230.   Published online 2023 April 3    DOI: http://dx.doi.org/10.4143/crt.2023.364
      
1231 The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma
Seong Yong Park, Hong Kwan Kim, Yeong Jeong Jeon, Junghee Lee, Jong Ho Cho, Yong Soo Choi, Young Mog Shim, Jae Il Zo
KMSID: 1516084166   Cancer Res Treat. 2023;55(4):1231-1239.   Published online 2023 April 24    DOI: http://dx.doi.org/10.4143/crt.2022.1417
      
1240 Development and Validation of Models to Predict Lymph Node Metastasis in Early Gastric Cancer Using Logistic Regression and Gradient Boosting Machine Methods
Hae Dong Lee, Kyung Han Nam, Cheol Min Shin, Hye Seung Lee, Young Hoon Chang, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee, Sang-Hoon Ahn, Hyung-Ho Kim
KMSID: 1516084169   Cancer Res Treat. 2023;55(4):1240-1249.   Published online 2023 March 21    DOI: http://dx.doi.org/10.4143/crt.2022.1330
      
1250 A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10)
Keun-Wook Lee, Dae Young Zang, Min-Hee Ryu, Hye Sook Han, Ki Hyang Kim, Mi-Jung Kim, Sung Ae Koh, Sung Sook Lee, Dong-Hoe Koo, Yoon Ho Ko, Byeong Seok Sohn, Jin Won Kim, Jin Hyun Park, Byung-Ho Nam, In Sil Choi
KMSID: 1516084301   Cancer Res Treat. 2023;55(4):1250-1260.   Published online 2023 May 25    DOI: http://dx.doi.org/10.4143/crt.2023.333
      
1261 Clinical Significance of Combining Preoperative and Postoperative Albumin-Bilirubin Score in Colorectal Cancer
Doyoun Kim, Jae-Hoon Lee, Eun-Suk Cho, Su-Jin Shin, Hye Sun Lee, Hwa-Hee Koh, Kang Young Lee, Jeonghyun Kang
KMSID: 1516084170   Cancer Res Treat. 2023;55(4):1261-1269.   Published online 2023 April 17    DOI: http://dx.doi.org/10.4143/crt.2022.1444
      
1270 Specific Mutations in APC, with Prognostic Implications in Metastatic Colorectal Cancer
Huan Peng, Jun Ying, Jia Zang, Hao Lu, Xiaokai Zhao, Pengmin Yang, Xintao Wang, Jieyi Li, Ziying Gong, Daoyun Zhang, Zhiguo Wang
KMSID: 1516084186   Cancer Res Treat. 2023;55(4):1270-1280.   Published online 2023 April 24    DOI: http://dx.doi.org/10.4143/crt.2023.415
      
1281 Differential Perspectives by Specialty on Oligometastatic Colorectal Cancer: A Korean Oligometastasis Working Group’s Comparative Survey Study
Won Kyung Cho, Gyu Sang Yoo, Chai Hong Rim, Jae-Uk Jeong, Eui Kyu Chie, Yong Chan Ahn, Hyeon-Min Cho, Jun Won Um, Yang-Gun Suh, Ah Ram Chang, Jong Hoon Lee
KMSID: 1516084191   Cancer Res Treat. 2023;55(4):1281-1290.   Published online 2023 June 7    DOI: http://dx.doi.org/10.4143/crt.2023.479
      
1291 ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer
Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-kun Lee, Hong Jae Chon
KMSID: 1516084167   Cancer Res Treat. 2023;55(4):1291-1302.   Published online 2023 May 3    DOI: http://dx.doi.org/10.4143/crt.2022.1450
      
1303 Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma
Kum Hei Ryu, Sunhwa Park, Jung Won Chun, Eunhae Cho, Jongmun Choi, Dong-Eun Lee, Hyoeun Shim, Yun-Hee Kim, Sung-Sik Han, Sang-Jae Park, Sang Myung Woo, Sun-Young Kong
KMSID: 1516084182   Cancer Res Treat. 2023;55(4):1303-1312.   Published online 2023 April 3    DOI: http://dx.doi.org/10.4143/crt.2023.291
      
1313 Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection
Dong-Hoon Lim, Hyunseok Yoon, Kyu-pyo Kim, Baek-Yeol Ryoo, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Song Cheol Kim, Seung-Mo Hong, Jaewon Hyung, Changhoon Yoo
KMSID: 1516084187   Cancer Res Treat. 2023;55(4):1313-1320.   Published online 2023 May 4    DOI: http://dx.doi.org/10.4143/crt.2023.452
      
1321 Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 Expression
Xianglai Xu, Ying Wang, Zhaoyi Chen, Yanjun Zhu, Jiajun Wang, Jianming Guo
KMSID: 1516084171   Cancer Res Treat. 2023;55(4):1321-1336.   Published online 2023 April 3    DOI: http://dx.doi.org/10.4143/crt.2022.1532
      
1337 TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort
Sang Hun Song, Jaewon Lee, Young Hwii Ko, Jong Wook Kim, Seung Il Jung, Seok Ho Kang, Jinsung Park, Ho Kyung Seo, Hyung Joon Kim, Byong Chang Jeong, Tae-Hwan Kim, Se Young Choi, Jong Kil Nam, Ja Yoon Ku, Kwan Joong Joo, Won Sik Jang, Young Eun Yoon, Seok Joong Yun, Sung-Hoo Hong, Jong Jin Oh
KMSID: 1516084188   Cancer Res Treat. 2023;55(4):1337-1345.   Published online 2023 April 17    DOI: http://dx.doi.org/10.4143/crt.2023.417
      
1346 Safety and Tolerability of Weekly Genexol-PM, a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel, with Carboplatin in Gynecologic Cancer: A Phase I Study
So Hyun Nam, Shin-Wha Lee, Young-Jae Lee, Yong Man Kim
KMSID: 1516084168   Cancer Res Treat. 2023;55(4):1346-1354.   Published online 2023 May 15    DOI: http://dx.doi.org/10.4143/crt.2022.1436
      
1355 Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study
Yu Ri Kim, Jin Seok Kim, Won Seog Kim, Hyeon Seok Eom, Deok-Hwan Yang, Sung Hwa Bae, Hyo Jung Kim, Jae Hoon Lee, Suk-Joong Oh, Sung-Soo Yoon, Jae-Yong Kwak, Chul Won Choi, Min Kyoung Kim, Sung Young Oh, Hye Jin Kang, Seung Hyun Nam, Hyeok Shim, Joon Seong Park, Yeung-Chul Mun, Cheolwon Suh
KMSID: 1516084178   Cancer Res Treat. 2023;55(4):1355-1362.   Published online 2023 March 30    DOI: http://dx.doi.org/10.4143/crt.2023.271
      
1363 Long-term Complete Remission of Decitabine-Primed Tandem CD19/CD22 CAR-T Therapy with PD-1 and BTK Inhibitors Maintenance in a Refractory Primary Central Nervous System Lymphoma Patient
Rui Zou, Xiao Zhou, Hailing Liu, Peng Wang, Fan Xia, Liqing Kang, Lei Yu, Depei Wu, Zhengming Jin, Changju Qu
KMSID: 1516084185   Cancer Res Treat. 2023;55(4):1363-1368.   Published online 2023 June 14    DOI: http://dx.doi.org/10.4143/crt.2023.371
      
Articles from Cancer Research and Treatment are provided here courtesy of Korean Cancer Association